SCOPUS 정보 검색 플랫폼

British Journal of Cancer

Volumn 99, Issue , 2008, Pages S96-S97

Survival from kidney cancer in england and wales up to 2001

(1) Hancock, B W a

a WESTON PARK HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2; SORAFENIB; SUNITINIB;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; HUMAN; KIDNEY CANCER; KIDNEY SURGERY; NOTE; OBESITY; PRIORITY JOURNAL; SMOKING; UNITED KINGDOM;

CARCINOMA; ENGLAND; FEMALE; FORECASTING; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; SURVIVAL ANALYSIS; WALES;

EID: 52449085446 PISSN: 00070920 EISSN: 15321827 Source Type: Journal
DOI: 10.1038/sj.bjc.6604602 Document Type: Article

Times cited : (1)

References (6)

1
- 33846164111
- Renal cell carcinoma–molecular pathways and therapies
- Brugarolas J (2007) Renal cell carcinoma–molecular pathways and therapies. N Engl J Med 356: 185–187
- (2007) N Engl J Med , vol.356 , pp. 185-187
- Brugarolas, J.¹

2
- 33846148701
- Sorafenib in advanced clear-cell renal-cell carcinoma
- Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, TARGET Study Group (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125–134
- (2007) N Engl J Med , vol.356 , pp. 125-134
- Escudier, B.¹ Eisen, T.² Stadler, W.M.³ Szczylik, C.⁴ Oudard, S.⁵ Siebels, M.⁶ Negrier, S.⁷ Chevreau, C.⁸ Solska, E.⁹ Desai, A.A.¹⁰ Rolland, F.¹¹ Demkow, T.¹² Hutson, T.E.¹³ Gore, M.¹⁴ Freeman, S.¹⁵ Schwartz, B.¹⁶ Shan, M.¹⁷ Simantov, R.¹⁸ Bukowski, R.M.¹⁹

3
- 33749441449
- Epidemiologic aspects of renal cell carcinoma
- McLaughlin JK, Lipworth L, Tarone RE (2006) Epidemiologic aspects of renal cell carcinoma. Semin Oncol 33: 527–533
- (2006) Semin Oncol , vol.33 , pp. 527-533
- McLaughlin, J.K.¹ Lipworth, L.² Tarone, R.E.³

4
- 33846181370
- Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
- Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Eng J Med 356: 115–124
- (2007) N Eng J Med , vol.356 , pp. 115-124
- Motzer, R.J.¹ Hutson, T.E.² Tomczak, P.³ Michaelson, M.D.⁴ Bukowski, R.M.⁵ Rixe, O.⁶ Oudard, S.⁷ Negrier, S.⁸ Szczylik, C.⁹ Kim, S.T.¹⁰ Chen, I.¹¹ Bycott, P.W.¹² Baum, C.M.¹³ Figlin, R.A.¹⁴

5
- 33749631580
- Prognostic factors in renal cell carcinoma
- Shuch BM, Lam JS, Belldegrun AS, Figlin RA (2006) Prognostic factors in renal cell carcinoma. Semin Oncol 33: 563–575
- (2006) Semin Oncol , vol.33 , pp. 563-575
- Shuch, B.M.¹ Lam, J.S.² Belldegrun, A.S.³ Figlin, R.A.⁴

6
- 52449107992
- Survival from cancers of the kidney and ureter in england and wales up to 2001
- Westlake S, Cooper N, Rachet B, Coleman MP (2008) Survival from cancers of the kidney and ureter in england and wales up to 2001. Br J Cancer 99(Suppl 1): S93–S95
- (2008) Br J Cancer , vol.99 , Issue.S1
- Westlake, S.¹ Cooper, N.² Rachet, B.³ Coleman, M.P.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.